Sholpan Akhelova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sholpan Akhelova has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Aigul Jussupkaliyeva1 shared publication
- Akerke Amirkhanova
School of Pharmacy, S.D. Asfendiyarov Kazakh National Medical University, Tole-bi 94, Almaty 050012, Kazakhstan
1 shared publication - Aknur Turgumbayeva
Al-Farabi Kazakh National University, Almaty, Kazakhstan
1 shared publication Daniyar Abdambayev
Asfendiyarov Kazakh National Medical University KazNMU Almaty Kazakhstan
1 shared publication- Gulnaz Absattarovna Seitimova
Faculty of Chemistry and Chemical Technology, al-Farabi Kazakh National University, Almaty 050040, Kazakhstan
1 shared publication - Kairat Zhakipbekov
Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan
1 shared publication
Latest Publications
- Open Access
- 31 March 2026
- Published by Scientific Center for Biological Research in Journal of Biological Research
- Vol. 1 (1) , 9-15
Medicinal plant raw materials in the pharmaceutical market of Kazakhstan: a comparative analysis of registered products in 2020 and 2025.
Medicinal plant raw materials are the basis of herbal preparations in medical practice, and studying their range on the pharmaceutical market of Kazakhstan allows us to assess development trends, product expansion, and improvement of quality control standards. The aim of the study was to conduct a comparative analysis of the range, morphological groups, and composition of domestic producers of medicinal plant raw materials registered in the State Register of Medicines of the Republic of Kazakhstan in 2020 and 2025, identifying changes in the nomenclature and distribution according to the ATC (Anatomical Therapeutic Chemical) classification. Open data from the register was used, a retrospective analysis of the quantity and distribution of raw materials by morphological groups and ATC categories was carried out, and information about manufacturers was systematized with verification of botanical names in Microsoft Excel. The results showed that the total number of registered raw materials remained stable (26 items), with Zerde-Fito LLP being the main manufacturer. The emergence of new manufacturers – Daulet-Farm LLP and Karaganda Pharmaceutical Plant LLP was accompanied by the registration of previously absent species, including parmelia thalli and salt marsh grass. The ATС categories have expanded to include new therapeutic areas, and the nomenclature of some species has been refined. The market for medicinal plant raw materials in Kazakhstan remains stable in terms of quantity, while at the same time, there is a structural renewal of the product range, the emergence of new manufacturers, and harmonization of the nomenclature, reflecting the development of phytotherapy and the strengthening of the national pharmaceutical sector.
- 31 March 2026
- Published by Scientific Center for Biological Research in Journal of Biological Research
- Vol. 1 (1) , 9-15
Open AccessMedicinal plant raw materials in the pharmaceutical market of Kazakhstan: a comparative analysis of registered products in 2020 and 2025.
Medicinal plant raw materials are the basis of herbal preparations in medical practice, and studying their range on the pharmaceutical market of Kazakhstan allows us to assess development trends, product expansion, and improvement of quality control standards. The aim of the study was to conduct a comparative analysis of the range, morphological groups, and composition of domestic producers of medicinal plant raw materials registered in the State Register of Medicines of the Republic of Kazakhstan in 2020 and 2025, identifying changes in the nomenclature and distribution according to the ATC (Anatomical Therapeutic Chemical) classification. Open data from the register was used, a retrospective analysis of the quantity and distribution of raw materials by morphological groups and ATC categories was carried out, and information about manufacturers was systematized with verification of botanical names in Microsoft Excel. The results showed that the total number of registered raw materials remained stable (26 items), with Zerde-Fito LLP being the main manufacturer. The emergence of new manufacturers – Daulet-Farm LLP and Karaganda Pharmaceutical Plant LLP was accompanied by the registration of previously absent species, including parmelia thalli and salt marsh grass. The ATС categories have expanded to include new therapeutic areas, and the nomenclature of some species has been refined. The market for medicinal plant raw materials in Kazakhstan remains stable in terms of quantity, while at the same time, there is a structural renewal of the product range, the emergence of new manufacturers, and harmonization of the nomenclature, reflecting the development of phytotherapy and the strengthening of the national pharmaceutical sector.
- Open Access
- 5 December 2022
- Published by Pensoft Publishers in Pharmacia
- Vol. 69 (4) , 1019-1026
Study of phytochemical compounds of Plantago major leaves grown in Kazakhstan
Leaves of Plantago major have been used for centuries to treat diseases relating to skin, digestive organs and blood circulation like wounds, inflammation and hypertension. P. major leaves contain biologically active substance and naturally compounds such as essential oils, minerals and amino acids beside polysaccharides, lipids, caffeic acid and its derivatives, iridoid glycosides, flavonoids and terpenoids. This work carried out an examination of Plantago major leaves in terms of phytochemical composition of methanol extract. The leaves contents in chosen nutrients, specifically amino acids and minerals, are moreover depicted. Gas Chromatography -Mass Spectrometry analysis identified the presence of 31 phytochemical compounds and a total amount of 20 amino acids (essential and nonessential) justifying its use as drugs and biological active supplements and its mineral content showed the presence of 7 essential chemical elements in Plantago major leaves. Nonetheless, additional research into this plant is needed because it has the potential to be used to development of new drugs and biological active supplements.
- 5 December 2022
- Published by Pensoft Publishers in Pharmacia
- Vol. 69 (4) , 1019-1026
Open AccessStudy of phytochemical compounds of Plantago major leaves grown in Kazakhstan
Leaves of Plantago major have been used for centuries to treat diseases relating to skin, digestive organs and blood circulation like wounds, inflammation and hypertension. P. major leaves contain biologically active substance and naturally compounds such as essential oils, minerals and amino acids beside polysaccharides, lipids, caffeic acid and its derivatives, iridoid glycosides, flavonoids and terpenoids. This work carried out an examination of Plantago major leaves in terms of phytochemical composition of methanol extract. The leaves contents in chosen nutrients, specifically amino acids and minerals, are moreover depicted. Gas Chromatography -Mass Spectrometry analysis identified the presence of 31 phytochemical compounds and a total amount of 20 amino acids (essential and nonessential) justifying its use as drugs and biological active supplements and its mineral content showed the presence of 7 essential chemical elements in Plantago major leaves. Nonetheless, additional research into this plant is needed because it has the potential to be used to development of new drugs and biological active supplements.